FDA Title 21 CFR Part 11 is the criteria by which FDA considers electronic records and signatures, and handwritten signatures affixed on electronic records, to be reliable, trustworthy and generally equivalent to paper records and to handwritten signatures affixed on paper.

This part applies to electronic records created, modified, maintained, filed, retrieved, or transmitted under any record requirements established by FDA regulations.